에 대한 추가 정보 4-Oxo-Dimeric-Isotretinoin
모약물
IsotretinoinIUPAC명
(2Z, 4E, 6E, 8E)-3, 7-dimethyl-9-((E)-2, 6, 6-trimethyl-4-((2E, 4E)-3-methyl-5-(2, 6, 6-trimethylcyclohex-1-en-1-yl)penta-2, 4-dien-1-ylidene)-3-oxocyclohex-1-en-1-yl)nona-2, 4, 6, 8-tetraenoic acid약전 동의어
N/AOther Synonyms
N/ASMILES
O=C(O)/C=C(C)\C=C\C=C(C)\C=C\C1=C(C)C(/C(CC1(C)C)=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)=OInChI
InChI=1S/C35H46O3/c1-24(12-10-13-26(3)22-32(36)37)17-20-31-28(5)33(38)29(23-35(31, 8)9)18-15-25(2)16-19-30-27(4)14-11-21-34(30, 6)7/h10, 12-13, 15-20, 22H, 11, 14, 21, 23H2, 1-9H3, (H, 36, 37)/b13-10+, 19-16+, 20-17+, 24-12+, 25-15+, 26-22-, 29-18+설명
The 4-Oxo-Dimeric-Isotretinoin standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Isotretinoin. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes.
견적 요청
"*" indicates required fields








